Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2020 | 12-2019 | 04-2019 | 12-2018 | 04-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90 | N/A | 43 | 43 | N/A |
| Other current assets | 101 | 0 | 206 | 1,458 | 0 |
| TOTAL | $1,814 | $N/A | $1,501 | $1,501 | $N/A |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $1,814 | $N/A | $1,501 | $1,501 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 992 | 0 | 1,184 | 0 | 0 |
| TOTAL | $992 | $N/A | $1,184 | $1,184 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $992 | $N/A | $1,184 | $1,184 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 7 | N/A | 6 | N/A | N/A |
| Retained earnings | -11,786 | N/A | -7,376 | -7,376 | N/A |
| Other shareholders' equity | -14,983 | 0 | -15,000 | 7,693 | 0 |
| TOTAL | $822 | $0 | $317 | $317 | $N/A |
| Total Liabilities And Equity | $1,814 | $0 | $1,501 | $1,501 | $0 |